|
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next
|
|
| |
|
Jul '99
|
|
Therapeutic Gp160 HIV-1 Vaccine Provides Little Benefit
| |
The Nordic VAC-04 Study Group has found no apparent clinical benefit of immunization with recombinant HIV-1 gp160 (rgp160). |
|
|
Jul '99
|
|
Sexual Health of Teenagers in England and Wales
| |
from The British Medical Journal |
|
|
Jul '99
|
|
Condom Use Must Tripleto Curb AIDS
| |
A new report issued by the Johns Hopkins School of Public Health, titled "Closing the Gap," |
|
|
Jul '99
|
|
Pap Smear For Bottoms?
| |
Doctors may begin recommending Pap smears for men who engage in anal sex. |
|
|
Jul '99
|
|
Updated HIV Treatment Guidelines Available
| |
Newly updated government guidelines for the treatment of HIV disease are available in print and on the Web. |
|
|
Jul '99
|
|
Anti-HIV Medications and Street Drugs: Some Cocktails Don't Mix
| |
There hasn't been much research on how street drugs and HIV medications interact-- because there is little financial incentive for the pharmaceutical companies
to do the work, and because the government believes "just say no," is the only way to deal with
drugs. |
|
|
Jun '99
|
|
T-20: First of a New Class of Anti-HIV Drugs
| |
T-20 (also known as pentafuside, previously DP-178) is a powerful new experimental antiretroviral, and the most prominent of a new class of anti-HIV drugs, the
fusion inhibitors. |
|
|
May '99
|
|
Don't Overlook Eye Disturbances
| |
Between 70% and 80% of HIV positive patients may experience one or more ocular disorders as a result of their disease. |
|
|
May '99
|
|
Oral Famciclovir for the Suppression of Recurrent Genital Herpes
| |
Researchers report that oral famciclovir is an effective treatment for the suppression of genital herpes simplex virus in patients who experience frequent recurrences. |
|
|
May '99
|
|
Lipodystrophy: Possible Mechanisms
| |
No one knows for sure what is causing symptoms such as "Crix belly" or "buffalo hump" and associated loss of fat in the face, arms, and legs among those
using protease inhibitors. |
|
|
May '99
|
|
Neuropathy: Nutritional Prevention/Treatment
| |
We have heard good reports about a simple prevention or treatment regimen... |
|
|
May '99
|
|
Quiet Doesn't Mean Gone
| |
Commenting on tantalizing data suggesting that some patients may be able to suppress and "manage" HIV infection for months or years with the help of highly active therapy... |
|
|
Apr '99
|
|
HIV Traces in Semen
| |
Traces of the AIDS virus have been found in the semen of men who responded well to aggressive drug therapy, leading scientists to remind HIV-positive men to
continue practicing safe sex. |
|
|
Apr '99
|
|
Ziagen Marketed as New Option for Combination Drug Therapy
| |
Ziagen (abacavir sulfate) which is conveniently dosed with one pill twice daily and easily incorporated into multi-drug regimens, is now being marketed for use in
combination with other drugs to treat HIV and AIDS. |
|
|
Mar '99
|
|
Guidelines for PWAs with Pets
| |
HIV/AIDS patients should choose healthy adult animals as pets rather than puppies and kittens, and should have the animals examined immediately by
a veterinarian. |
|
|
Feb '99
|
|
New Strain of AIDS Virus Discovered in Africa
| |
French researchers have discovered a rare, new HIV strain that can avoid detection with standard screening tests. The strain was found in a
40-year-old Cameroonian women who died of AIDS complications in 1995. |
|
|
Jan '99
|
|
T-20 Results Published
| |
Complete results on the first multi-dose human trial of T-20 were published in
Nature Medicine. At the highest dose tested, patients treated with T-20 alone had a viral load drop of 1.96 logs in 14 days. |
|
|
Jan '99
|
|
Imiquimod: Role in HIV Treatment?
| |
A recent study indicates that oral imiquimod, an immune response modifier, may be useful in the treatment of HIV. |
|
|
Nov '98
|
|
Hydrea In Action
By: Robert Folan-Johnson
| |
Hydrea (or Hydroxyurea) has long been available to treat certain types of cancer, and recently, as a therapy for sickle cell disease. |
|
|
Oct '98
|
|
Geneva Medical Report Now on Web
| |
An excellent two-hour summary of major practical themes from the 12th World AIDS Conference, intended primarily for HIV care providers, is now available in both text and audio on the Web. |
|
|
Oct '98
|
|
Efavirenz (Sustiva) May Equal or Exceed Protease Inhibitor in Initial Antiretroviral Combination
| |
One of the most important treatment developments at the 12th World AIDS Conference... |
|
|
Oct '98
|
|
Hydroxyurea: Talk of Geneva
| |
Several significant developments related to hydroxyurea (HU) were discussed at the 12th World AIDS Conference in Geneva. |
|
|
Oct '98
|
|
AZT Protects Against HIV-Related Dementia
| |
Dr. Brian G. Gazzard of the Chelsea and Westminster Hospital in London and colleagues report in the July issue of the
Journal of Neurology, Neurosurgery, and
Psychiatry that the administration of
zidovudine (AZT) before the onset of AIDS and continued after the development of the disease helps protect against HIV-related dementia and opportunistic brain infections. |
|
|
Sep '98
|
|
Ritonavir Pill Shortage
| |
Abbott Laboratories, makers of the protease inhibitor Norvir (Ritonavir), has announced that manufacturing problems will result in a shortage of the drug in capsule form by the end of August. |
|
|
Sep '98
|
|
Metabolic Complications, Growth Hormone Treatment: New Studies Planned
| |
On June 12 the Community Research Initiative on AIDS (CRIA), located in New York City, announced that it will begin two studies of metabolic disorders... |
|
|
Sep '98
|
|
If You Are Exposed to HIV: Guidelines Published for Postexposure Prevention
| |
The US Centers for Disease Control and Prevention (CDC) has published guidelines for preventive treatment of healthcare workers accidentally exposed to HIV. |
|
|
Aug '98
|
|
SP-303: New Treatment for AIDS-Associated Diarrhea
| |
A study of 51 HIV-positive subjects with a history of a CD4 count below 200 or an AIDS- defining illness... |
|
|
Aug '98
|
|
Indinavir Can Be Taken with Regular Meals When Administered with Ritonavir
| |
Indinavir (Crixivan) and ritonavir (Norvir) are potent HIV protease inhibitors. |
|
|
Aug '98
|
|
Ritonavir-Containing Dual Protease Inhibitor Regimens May Have Synergistic Antiviral Effects in Patients
| |
The combination of ritonavir and saquinavir with or without reverse transcriptase inhibitor regimens has been shown to be highly active in numerous clinical studies. |
|
|
Aug '98
|
|
Twenty-Four Week Follow-Up of Indinavir in Combination with Efavirenz, Thrice versus Twice Daily Dosing
| |
Simplified dosing regimens with potent antiretroviral therapy may improve adherence and outcome of HIV therapy. |
|
|
|
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next
|
Advertise with us
Subscriptions
Contact us
Site map
Translate
